Industry Roundtable Discussion: Formulating Oncology-Biologic Drug Products for IV and SC Administration

13 Oct 2026
Biologics Formulation
  • Protein stability.
  • Aggregation control.
  • High-concentration biologics.
Speakers
Ramesh Kashi
Ramesh Kashi, Senior Scientific Advisor - Formerly Bristol-Myers Squibb